@article{GS20400,
author = {Ryan Kanai and John M. Lamar},
title = {TAZ teases T cells with PD-L1},
journal = {Gland Surgery},
volume = {8},
number = {4},
year = {2018},
keywords = {},
abstract = {Metastatic cancer continues to be a devastating disease with few effective treatment options. One promising approach that has emerged recently is immunotherapy, and the immune checkpoint protein programmed death-ligand 1 (PD-L1) has garnered particular interest given its role in immune system evasion by cancer cells (1,2).},
issn = {2227-8575}, url = {https://gs.amegroups.org/article/view/20400}
}